http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Tue, 01 Sep 2026 08:00:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Absci+to+Participate+in+Upcoming+Investor+Conferences/27008986.html <p align="justify">VANCOUVER, Wash. and NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will be participating in the following upcoming investor conferences:</p> <ul type="disc"><li style="text-align:justify;"><strong>H.C. Wainwright 28</strong>^{<strong>th</strong>}<strong> Annual Global Investment Conference (New York, NY)</strong><br /></li></ul> <p align="justify">Fireside chat on Tuesday, September 15^th at 3:30 p.m. Eastern Time / 12:30 p.m. Pacific Time</p> <ul type="disc"><li style="text-align:justify;"><strong>Morgan Stanley 24</strong>^{<strong>th</strong>}<strong> Annual Global Healthcare Conference (New York, NY)</strong><br /></li></ul> <p align="justify">Fireside chat on Wednesday, September 16^th at 7:45 a.m. Eastern http://www.streetinsider.com/Press+Releases/Absci+to+Participate+in+Upcoming+Investor+Conferences/27008986.html Tue, 01 Sep 2026 08:00:00 -0400 ABSI http://www.streetinsider.com/Globe+Newswire/Absci+to+Participate+in+Upcoming+Investor+Conferences/27008986.html <p align="justify">VANCOUVER, Wash. and NEW YORK, Sept. 01, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will be participating in the following upcoming investor conferences:</p> <ul type="disc"><li style="text-align:justify;"><strong>H.C. Wainwright 28</strong>^{<strong>th</strong>}<strong> Annual Global Investment Conference (New York, NY)</strong><br /></li></ul> <p align="justify">Fireside chat on Tuesday, September 15^th at 3:30 p.m. Eastern Time / 12:30 p.m. Pacific Time</p> <ul type="disc"><li style="text-align:justify;"><strong>Morgan Stanley 24</strong>^{<strong>th</strong>}<strong> Annual Global Healthcare Conference (New York, NY)</strong><br /></li></ul> <p align="justify">Fireside chat on Wednesday, September 16^th at 7:45 a.m. Eastern http://www.streetinsider.com/Globe+Newswire/Absci+to+Participate+in+Upcoming+Investor+Conferences/27008986.html Tue, 01 Sep 2026 08:00:00 -0400 ABSI http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html <p><strong>News Provided by USA News Group on behalf of MindWalk Holdings Corp.</strong></p><p align="left">NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=" rel="nofollow" target="_blank">USA News Group</a><strong> News Commentary - </strong>Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html Wed, 19 Aug 2026 08:56:00 -0400 ABCL ABCL ABSI ABSI AZN AZN HYFT HYFT LLY LLY http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html <p><strong>News Provided by USA News Group on behalf of MindWalk Holdings Corp.</strong></p><p align="left">NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=" rel="nofollow" target="_blank">USA News Group</a><strong> News Commentary - </strong>Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html Wed, 19 Aug 2026 08:56:00 -0400 ABCL ABCL ABSI ABSI AZN AZN HYFT HYFT LLY LLY http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html <p><strong>News Provided by USA News Group on behalf of MindWalk Holdings Corp.</strong></p><p align="left">NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=" rel="nofollow" target="_blank">USA News Group</a><strong> News Commentary - </strong>Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html Wed, 19 Aug 2026 08:56:00 -0400 ABCL ABCL ABSI ABSI AZN AZN HYFT HYFT LLY LLY http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html <p><strong>News Provided by USA News Group on behalf of MindWalk Holdings Corp.</strong></p><p align="left">NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=" rel="nofollow" target="_blank">USA News Group</a><strong> News Commentary - </strong>Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html Wed, 19 Aug 2026 08:56:00 -0400 ABCL ABCL ABSI ABSI AZN AZN HYFT HYFT LLY LLY http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html <p><strong>News Provided by USA News Group on behalf of MindWalk Holdings Corp.</strong></p><p align="left">NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=" rel="nofollow" target="_blank">USA News Group</a><strong> News Commentary - </strong>Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html Wed, 19 Aug 2026 08:56:00 -0400 ABCL ABCL ABSI ABSI AZN AZN HYFT HYFT LLY LLY http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html <p><strong>News Provided by USA News Group on behalf of MindWalk Holdings Corp.</strong></p><p align="left">NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=" rel="nofollow" target="_blank">USA News Group</a><strong> News Commentary - </strong>Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html Wed, 19 Aug 2026 08:56:00 -0400 ABCL ABCL ABSI ABSI AZN AZN HYFT HYFT LLY LLY http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html <p><strong>News Provided by USA News Group on behalf of MindWalk Holdings Corp.</strong></p><p align="left">NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=" rel="nofollow" target="_blank">USA News Group</a><strong> News Commentary - </strong>Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html Wed, 19 Aug 2026 08:56:00 -0400 ABCL ABCL ABSI ABSI AZN AZN HYFT HYFT LLY LLY http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html <p><strong>News Provided by USA News Group on behalf of MindWalk Holdings Corp.</strong></p><p align="left">NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=" rel="nofollow" target="_blank">USA News Group</a><strong> News Commentary - </strong>Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html Wed, 19 Aug 2026 08:56:00 -0400 ABCL ABCL ABSI ABSI AZN AZN HYFT HYFT LLY LLY http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html <p><strong>News Provided by USA News Group on behalf of MindWalk Holdings Corp.</strong></p><p align="left">NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=" rel="nofollow" target="_blank">USA News Group</a><strong> News Commentary - </strong>Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html Wed, 19 Aug 2026 08:56:00 -0400 ABCL ABCL ABSI ABSI AZN AZN HYFT HYFT LLY LLY http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html <p><strong>News Provided by USA News Group on behalf of MindWalk Holdings Corp.</strong></p><p align="left">NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=" rel="nofollow" target="_blank">USA News Group</a><strong> News Commentary - </strong>Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that http://www.streetinsider.com/Press+Releases/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html Wed, 19 Aug 2026 08:56:00 -0400 ABCL ABCL ABSI ABSI AZN AZN HYFT HYFT LLY LLY http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html <p><strong>News Provided by USA News Group on behalf of MindWalk Holdings Corp.</strong></p><p align="left">NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=" rel="nofollow" target="_blank">USA News Group</a><strong> News Commentary - </strong>Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html Wed, 19 Aug 2026 08:56:00 -0400 ABCL ABCL ABSI ABSI AZN AZN HYFT HYFT LLY LLY http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html <p><strong>News Provided by USA News Group on behalf of MindWalk Holdings Corp.</strong></p><p align="left">NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=" rel="nofollow" target="_blank">USA News Group</a><strong> News Commentary - </strong>Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html Wed, 19 Aug 2026 08:56:00 -0400 ABCL ABCL ABSI ABSI AZN AZN HYFT HYFT LLY LLY http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html <p><strong>News Provided by USA News Group on behalf of MindWalk Holdings Corp.</strong></p><p align="left">NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=" rel="nofollow" target="_blank">USA News Group</a><strong> News Commentary - </strong>Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html Wed, 19 Aug 2026 08:56:00 -0400 ABCL ABCL ABSI ABSI AZN AZN HYFT HYFT LLY LLY http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html <p><strong>News Provided by USA News Group on behalf of MindWalk Holdings Corp.</strong></p><p align="left">NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=" rel="nofollow" target="_blank">USA News Group</a><strong> News Commentary - </strong>Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html Wed, 19 Aug 2026 08:56:00 -0400 ABCL ABCL ABSI ABSI AZN AZN HYFT HYFT LLY LLY http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html <p><strong>News Provided by USA News Group on behalf of MindWalk Holdings Corp.</strong></p><p align="left">NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=" rel="nofollow" target="_blank">USA News Group</a><strong> News Commentary - </strong>Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html Wed, 19 Aug 2026 08:56:00 -0400 ABCL ABCL ABSI ABSI AZN AZN HYFT HYFT LLY LLY http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html <p><strong>News Provided by USA News Group on behalf of MindWalk Holdings Corp.</strong></p><p align="left">NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=" rel="nofollow" target="_blank">USA News Group</a><strong> News Commentary - </strong>Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html Wed, 19 Aug 2026 08:56:00 -0400 ABCL ABCL ABSI ABSI AZN AZN HYFT HYFT LLY LLY http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html <p><strong>News Provided by USA News Group on behalf of MindWalk Holdings Corp.</strong></p><p align="left">NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=" rel="nofollow" target="_blank">USA News Group</a><strong> News Commentary - </strong>Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html Wed, 19 Aug 2026 08:56:00 -0400 ABCL ABCL ABSI ABSI AZN AZN HYFT HYFT LLY LLY http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html <p><strong>News Provided by USA News Group on behalf of MindWalk Holdings Corp.</strong></p><p align="left">NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=" rel="nofollow" target="_blank">USA News Group</a><strong> News Commentary - </strong>Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html Wed, 19 Aug 2026 08:56:00 -0400 ABCL ABCL ABSI ABSI AZN AZN HYFT HYFT LLY LLY http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html <p><strong>News Provided by USA News Group on behalf of MindWalk Holdings Corp.</strong></p><p align="left">NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=" rel="nofollow" target="_blank">USA News Group</a><strong> News Commentary - </strong>Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html Wed, 19 Aug 2026 08:56:00 -0400 ABCL ABCL ABSI ABSI AZN AZN HYFT HYFT LLY LLY http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html <p><strong>News Provided by USA News Group on behalf of MindWalk Holdings Corp.</strong></p><p align="left">NEW YORK, Aug. 19, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Tuhl8SoGdqXkIoZcmiFpyrNVstQDwhTHtEEDZyhvi4W7dn-jnhNRtC8cmX1UMw-F3MAMiRzcTRtl5HibqcpvgSSrc-L333VVG8_-f6NSlyo=" rel="nofollow" target="_blank">USA News Group</a><strong> News Commentary - </strong>Artificial intelligence has become the most talked-about tool in drug discovery, promising to compress the years and billions of dollars it takes to turn a biological insight into a medicine. But most of the AI now aimed at biology shares a hidden limitation: it reasons primarily from sequence, the raw genetic letters of DNA, RNA, and proteins. Two molecules whose sequences look alike are treated as related; two that http://www.streetinsider.com/Globe+Newswire/Most+AI+Drug+Discovery+Reads+the+Genetic+Code.+The+Next+Wave+Is+Learning+to+Read+What+the+Code+Actually+Does./26947782.html Wed, 19 Aug 2026 08:56:00 -0400 ABCL ABCL ABSI ABSI AZN AZN HYFT HYFT LLY LLY http://www.streetinsider.com/Earnings/Absci+Corporation+%28ABSI%29+Misses+Q2+EPS+by+2c/26906188.html <p>Absci Corporation (NASDAQ: ABSI) reported Q2 EPS of ($0.21), $0.02 worse than the analyst estimate of ($0.19). Revenue for the quarter came in at $300 thousand versus the consensus estimate of $1.01 million.</p><p>For earnings history and earnings-related data on Absci Corporation (ABSI) <a href="http://www.streetinsider.com/ec_earnings.php?q=ABSI">click here</a>.</p> http://www.streetinsider.com/Earnings/Absci+Corporation+%28ABSI%29+Misses+Q2+EPS+by+2c/26906188.html Tue, 11 Aug 2026 16:24:50 -0400 ABSI http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Absci+Corp++++++++++++++++For%3A+Jun+30/26905738.html si-local-file:///var/storage/secattach/20260811/26905738.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Absci+Corp++++++++++++++++For%3A+Jun+30/26905738.html Tue, 11 Aug 2026 16:09:00 -0400 ABSI O.51016270 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Absci+Corp++++++++++++++++For%3A+Jun+30/26905738.html si-local-file:///var/storage/secattach/20260811/26905738.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Absci+Corp++++++++++++++++For%3A+Jun+30/26905738.html Tue, 11 Aug 2026 16:09:00 -0400 ABSI O.51016270